Sirtuin 1 (SIRT1) NAD+-dependent deacetylase regulates energy metabolism by modulating expression of genes involved in gluconeogenesis and other liver fasting responses. While many effects of SIRT1 on gene expression are mediated by deacetylation and activation of peroxisome proliferator activated receptor coactivator α (PGC-1α), SIRT1 also binds directly to DNA bound transcription factors, including nuclear receptors (NRs), to modulate their activity. Since thyroid hormone receptor β1 (TRβ1) regulates several SIRT1 target genes in liver and interacts with PGC-1α, we hypothesized that SIRT1 may influence TRβ1. Here, we confirm that SIRT1 cooperates with PGC-1α to enhance response to triiodothyronine, T3. We also find, however, that SIRT1 stimulates TRβ1 activity in a manner that is independent of PGC-1α but requires SIRT1 deacetylase activity. SIRT1 interacts with TRβ1 in vitro, promotes TRβ1 deacetylation in the presence of T3 and enhances ubiquitin-dependent TRβ1 turnover; a common response of NRs to activating ligands. More surprisingly, SIRT1 knockdown only strongly inhibits T3 response of a subset of TRβ1 target genes, including glucose 6 phosphatase (G-6-Pc), and this is associated with blockade of TRβ1 binding to the G-6-Pc promoter. Drugs that target the SIRT1 pathway, resveratrol and nicotinamide, modulate T3 response at dual TRβ1/SIRT1 target genes. We propose that SIRT1 is a gene-specific TRβ1 co-regulator and TRβ1/SIRT1 interactions could play important roles in regulation of liver metabolic response. Our results open possibilities for modulation of subsets of TR target genes with drugs that influence the SIRT1 pathway.
References
[1]
Brent GA (2012) Mechanisms of thyroid hormone action. J Clin Invest. 122: 3035–3043.
[2]
Weiss RE, Ramos HE (2004) Thyroid hormone receptor subtypes and their interaction with steroid receptor coactivators. Vitam Horm. 68: 185–207.
[3]
Fondell JD (2013) The Mediator complex in thyroid hormone receptor action. Biochim Biophys Acta. 1830: 3867–3875.
[4]
Astapova I, Hollenberg AN (2013) The in vivo role of nuclear receptor corepressors in thyroid hormone action. Biochim Biophys Acta. 1830: 3876–3881.
[5]
Lonard DM, O’Malley BW (2009) Emerging roles of the ubiquitin proteasome system in nuclear hormone receptor signaling. Prog Mol Biol Transl Sci. 87: 117–135.
[6]
Brunelle M, Fayad T, Langlois MF (2011) Degradation of thyroid hormone receptor beta 1: existence of stable and unstable forms. Thyroid. 21: 311–318.
[7]
Weth O, Weth C, Bartkuhn M, Leers J, Uhle F, et al. (2010) Modular insulators: genome wide search for composite CTCF/thyroid hormone receptor binding sites. PLoS One. 5: e10119.
[8]
Weinhofer I, Kunze M, Rampler H, Forss-Petter S, Samarut J, et al. (2008) Distinct modulatory roles for thyroid hormone receptors TRalpha and TRbeta in SREBP1-activated ABCD2 expression. Eur J Cell Biol. 87: 933–945.
[9]
Yuan C, Nguyen P, Baxter JD, Webb P (2013) Distinct ligand-dependent and independent modes of thyroid hormone receptor (TR)/PGC-1alpha interaction. J Steroid Biochem Mol Biol. 133: 58–65.
[10]
Feige JN, Auwerx J (2007) Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 17: 292–301.
[11]
Weitzel JM, Hamann S, Jauk M, Lacey M, Filbry A, et al. (2003) Hepatic gene expression patterns in thyroid hormone-treated hypothyroid rats. J Mol Endocrinol. 31: 291–303.
[12]
Weitzel JM, Radtke C, Seitz HJ (2001) Two thyroid hormone-mediated gene expression patterns in vivo identified by cDNA expression arrays in rat. Nucleic Acids Res. 29: 5148–5155.
[13]
Zhang Y, Ma K, Song S, Elam MB, Cook GA, et al. (2004) Peroxisomal proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha) enhances the thyroid hormone induction of carnitine palmitoyltransferase I (CPT-I alpha). J Biol Chem. 279: 53963–53971.
[14]
Sadana P, Zhang Y, Song S, Cook GA, Elam MB, et al. (2007) Regulation of carnitine palmitoyltransferase I (CPT-Ialpha) gene expression by the peroxisome proliferator activated receptor gamma coactivator (PGC-1) isoforms. Mol Cell Endocrinol. 267: 6–16.
[15]
Attia RR, Connnaughton S, Boone LR, Wang F, Elam MB, et al. (2010) Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by thyroid hormone: role of the peroxisome proliferator-activated receptor gamma coactivator (PGC-1 alpha). J Biol Chem. 285: 2375–2385.
[16]
Schug TT, Li X (2011) Sirtuin 1 in lipid metabolism and obesity. Ann Med. 43: 198–211.
[17]
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell. 127: 1109–22.
[18]
Dominy JE Jr, Lee Y, Gerhart-Hines Z, Puigserver P (2010) Nutrient-dependent regulation of PGC-1alpha’s acetylation state and metabolic function through the enzymatic activities of Sirt1/GCN5. Biochim Biophys Acta. 1804: 1676–1683.
[19]
Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, et al. (2009) Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 9: 327–338.
[20]
Li X, Zhang S, Blander G, Tse JG, Krieger M, et al. (2007) SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell. 28: 91–106.
[21]
Kemper JK, Xiao Z, Ponugoti B, Miao J, Fang S, et al. (2009) FXR acetylation is normally dynamically regulated by p300 and SIRT1 but constitutively elevated in metabolic disease states. Cell Metab. 10: 392–404.
[22]
Wilson BJ, Tremblay AM, Deblois G, Sylvain-Drolet G, Giguère V, et al. (2010) An acetylation switch modulates the transcriptional activity of estrogen-related receptor alpha. Mol Endocrinol. 24: 1349–1358.
[23]
Liu YY, Brent GA (2010) Thyroid hormone crosstalk with nuclear receptor signaling in metabolic regulation. Trends Endocrinol Metab. 21: 166–73.
[24]
Thakran S, Sharma P, Attia RR, Hori RT, Deng X, et al. (2013) Role of sirtuin 1 in the regulation of hepatic gene expression by thyroid hormone. J Biol Chem. 288: 807–818.
[25]
Yuan C, Lin JZ, Sieglaff DH, Ayers SD, Denoto-Reynolds F, et al. (2012) Identical gene regulation patterns of T3 and selective thyroid hormone receptor modulator GC-1. Endocrinology. 153: 501–11.
[26]
Lin JZ, Sieglaff DH, Yuan C, Su J, Arumanayagam AS, et al. Gene specific actions of thyroid hormone receptor subtypes. PLoS One. 8: e52407.
[27]
Velasco LF, Togashi M, Walfish PG, Pessanha RP, Moura FN, et al. (2007) Thyroid hormone response element organization dictates the composition of active receptor. J Biol Chem. 282: 12458–12466.
[28]
Lin HY, Hopkins R, Cao HJ, Tang HY, Alexander C, et al. (2005) Acetylation of nuclear hormone receptor superfamily members: thyroid hormone causes acetylation of its own receptor by a mitogen-activated protein kinase-dependent mechanism. Steroids. 70: 444–449.
[29]
Sánchez-Pacheco A, Martínez-Iglesias O, Méndez-Pertuz M, Aranda A (2009) Residues K128, 132, and 134 in the thyroid hormone receptor-alpha are essential for receptor acetylation and activity. Endocrinology. 150: 5143–5152.
[30]
Lucas PC, Forman BM, Samuels HH, Granner DK (1991) Specificity of a retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoter: consequences of both retinoic acid and thyroid hormone receptor binding. Mol Cell Biol. 11: 6343.
[31]
Park EA, Jerden DC, Bahouth SW (1995) Regulation of phosphoenolpyruvate carboxykinase gene transcription by thyroid hormone involves two distinct binding sites in the promoter. Biochem J. 309: 913–919.
[32]
Giralt M, Park EA, Gurney AL, Liu JS, Hakimi P, et al. (1991) Identification of a thyroid hormone response element in the phosphoenolpyruvate carboxykinase (GTP) gene. Evidence for synergistic interaction between thyroid hormone and cAMP cis-regulatory elements. J Biol Chem. 266: 21991–21996.
[33]
Feng W, Ribeiro RC, Wagner RL, Nguyen H, Apriletti JW, et al. (1998) Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science. 280: 1747–1749.
[34]
Baxter JD, Webb P, (200Thyroid hormone mimetics: potential applications in atherosclerosis, obesity and type 2 diabetes. Nat Rev Drug Discov. 8: 308–320.
[35]
Du P, Kibbe WA, Lin SM (2008) Lumi: a pipeline for processing Illumina microarray. Bioinformatics. 24: 1547–1548.
[36]
Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology. 3.
[37]
Team RDC (2009) R: A language and environment for statistical computing. R Foundation for Statistical Computing: Vienna.
[38]
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological). 57: 289–300.
[39]
Hipp DR, SQLite.
[40]
Saeed AI, Sharov V, White J, Li J, Liang W, et al. (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques. 34: 374–378.
[41]
Cordeiro A, de Souza LL, Oliveira LS, Faustino LC, Santiago LA, et al. (2013) Thyroid hormone regulation of Sirtuin 1 expression and implications to integrated responses in fasted mice. Journal of Endocrinology. 216: 181–193.
[42]
Feng X, Jiang Y, Meltzer P, Yen PM (2000) Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol. Endocrinol. 14: 947–955.
[43]
Vujovic M, Nordstr？m K, Gauthier K, Flamant F, Visser TJ, et al. (2009) Interference of a mutant thyroid hormone receptor alpha 1 with hepatic glucose metabolism. Endocrinology. 150: 2940–2947.
[44]
Qiang L, Wang L, Kon N, Zhao W, Lee S, et al. (2012) Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of PPARγ. Cell. 150: 620–632.
